nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Dactinomycin—muscle cancer	0.197	0.227	CbGbCtD
Atazanavir—ABCC1—Vincristine—muscle cancer	0.121	0.14	CbGbCtD
Atazanavir—ABCC1—Etoposide—muscle cancer	0.111	0.128	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—muscle cancer	0.106	0.122	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—muscle cancer	0.0758	0.0872	CbGbCtD
Atazanavir—ABCC1—Methotrexate—muscle cancer	0.0735	0.0845	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—muscle cancer	0.0475	0.0547	CbGbCtD
Atazanavir—ABCB1—Vincristine—muscle cancer	0.0293	0.0337	CbGbCtD
Atazanavir—ABCB1—Etoposide—muscle cancer	0.0268	0.0309	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—muscle cancer	0.0183	0.021	CbGbCtD
Atazanavir—ABCB1—Methotrexate—muscle cancer	0.0177	0.0204	CbGbCtD
Atazanavir—CYP3A4—Vincristine—muscle cancer	0.0175	0.0202	CbGbCtD
Atazanavir—CYP3A4—Etoposide—muscle cancer	0.0161	0.0185	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—muscle cancer	0.011	0.0126	CbGbCtD
Atazanavir—Infection—Vincristine—muscle cancer	0.000322	0.00247	CcSEcCtD
Atazanavir—Diabetes mellitus—Doxorubicin—muscle cancer	0.000318	0.00244	CcSEcCtD
Atazanavir—Nervous system disorder—Vincristine—muscle cancer	0.000318	0.00244	CcSEcCtD
Atazanavir—Photosensitivity—Doxorubicin—muscle cancer	0.000315	0.00242	CcSEcCtD
Atazanavir—Decreased appetite—Dactinomycin—muscle cancer	0.000315	0.00242	CcSEcCtD
Atazanavir—Dysgeusia—Etoposide—muscle cancer	0.000315	0.00242	CcSEcCtD
Atazanavir—Hyperhidrosis—Vincristine—muscle cancer	0.000313	0.0024	CcSEcCtD
Atazanavir—Fatigue—Dactinomycin—muscle cancer	0.000313	0.0024	CcSEcCtD
Atazanavir—Back pain—Etoposide—muscle cancer	0.000311	0.00239	CcSEcCtD
Atazanavir—Pain—Dactinomycin—muscle cancer	0.00031	0.00238	CcSEcCtD
Atazanavir—Vascular purpura—Doxorubicin—muscle cancer	0.00031	0.00238	CcSEcCtD
Atazanavir—Anorexia—Vincristine—muscle cancer	0.000309	0.00237	CcSEcCtD
Atazanavir—Eczema—Doxorubicin—muscle cancer	0.000308	0.00236	CcSEcCtD
Atazanavir—Mood swings—Methotrexate—muscle cancer	0.000303	0.00232	CcSEcCtD
Atazanavir—Feeling abnormal—Dactinomycin—muscle cancer	0.000299	0.00229	CcSEcCtD
Atazanavir—Ill-defined disorder—Etoposide—muscle cancer	0.000298	0.00229	CcSEcCtD
Atazanavir—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000296	0.00227	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000295	0.00226	CcSEcCtD
Atazanavir—Increased appetite—Doxorubicin—muscle cancer	0.000295	0.00226	CcSEcCtD
Atazanavir—Insomnia—Vincristine—muscle cancer	0.000293	0.00225	CcSEcCtD
Atazanavir—Malaise—Etoposide—muscle cancer	0.00029	0.00222	CcSEcCtD
Atazanavir—Dermatitis bullous—Doxorubicin—muscle cancer	0.00029	0.00222	CcSEcCtD
Atazanavir—Breast disorder—Methotrexate—muscle cancer	0.000289	0.00222	CcSEcCtD
Atazanavir—Purpura—Doxorubicin—muscle cancer	0.000287	0.0022	CcSEcCtD
Atazanavir—Abdominal pain—Dactinomycin—muscle cancer	0.000287	0.0022	CcSEcCtD
Atazanavir—Body temperature increased—Dactinomycin—muscle cancer	0.000287	0.0022	CcSEcCtD
Atazanavir—Hypoglycaemia—Doxorubicin—muscle cancer	0.000284	0.00218	CcSEcCtD
Atazanavir—Loss of consciousness—Etoposide—muscle cancer	0.000283	0.00217	CcSEcCtD
Atazanavir—Decreased appetite—Vincristine—muscle cancer	0.000282	0.00216	CcSEcCtD
Atazanavir—Cough—Etoposide—muscle cancer	0.000281	0.00215	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Vincristine—muscle cancer	0.00028	0.00215	CcSEcCtD
Atazanavir—Fatigue—Vincristine—muscle cancer	0.000279	0.00214	CcSEcCtD
Atazanavir—Convulsion—Etoposide—muscle cancer	0.000279	0.00214	CcSEcCtD
Atazanavir—Hypertension—Etoposide—muscle cancer	0.000278	0.00213	CcSEcCtD
Atazanavir—Pain—Vincristine—muscle cancer	0.000277	0.00213	CcSEcCtD
Atazanavir—Constipation—Vincristine—muscle cancer	0.000277	0.00213	CcSEcCtD
Atazanavir—Pain in extremity—Doxorubicin—muscle cancer	0.000277	0.00212	CcSEcCtD
Atazanavir—Chest pain—Etoposide—muscle cancer	0.000274	0.0021	CcSEcCtD
Atazanavir—Eosinophilia—Methotrexate—muscle cancer	0.000274	0.0021	CcSEcCtD
Atazanavir—Affect lability—Doxorubicin—muscle cancer	0.000273	0.00209	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000272	0.00209	CcSEcCtD
Atazanavir—Pancreatitis—Methotrexate—muscle cancer	0.000271	0.00208	CcSEcCtD
Atazanavir—Discomfort—Etoposide—muscle cancer	0.00027	0.00208	CcSEcCtD
Atazanavir—Hypersensitivity—Dactinomycin—muscle cancer	0.000267	0.00205	CcSEcCtD
Atazanavir—Gastrointestinal pain—Vincristine—muscle cancer	0.000265	0.00203	CcSEcCtD
Atazanavir—Confusional state—Etoposide—muscle cancer	0.000265	0.00203	CcSEcCtD
Atazanavir—Cardiac arrest—Doxorubicin—muscle cancer	0.000263	0.00202	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—muscle cancer	0.000262	0.00201	CcSEcCtD
Atazanavir—Infection—Etoposide—muscle cancer	0.000261	0.002	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—muscle cancer	0.00026	0.002	CcSEcCtD
Atazanavir—Neutropenia—Methotrexate—muscle cancer	0.000258	0.00198	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—muscle cancer	0.000257	0.00198	CcSEcCtD
Atazanavir—Abdominal pain—Vincristine—muscle cancer	0.000256	0.00196	CcSEcCtD
Atazanavir—Body temperature increased—Vincristine—muscle cancer	0.000256	0.00196	CcSEcCtD
Atazanavir—Skin disorder—Etoposide—muscle cancer	0.000255	0.00196	CcSEcCtD
Atazanavir—Erectile dysfunction—Methotrexate—muscle cancer	0.000255	0.00195	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—muscle cancer	0.000254	0.00195	CcSEcCtD
Atazanavir—Hyperhidrosis—Etoposide—muscle cancer	0.000254	0.00195	CcSEcCtD
Atazanavir—Photosensitivity reaction—Methotrexate—muscle cancer	0.000252	0.00194	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—muscle cancer	0.00025	0.00192	CcSEcCtD
Atazanavir—Anorexia—Etoposide—muscle cancer	0.00025	0.00192	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000249	0.00191	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—muscle cancer	0.000248	0.0019	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—muscle cancer	0.000248	0.0019	CcSEcCtD
Atazanavir—Depression—Methotrexate—muscle cancer	0.000246	0.00189	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—muscle cancer	0.000245	0.00188	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000244	0.00187	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000244	0.00187	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—muscle cancer	0.000244	0.00187	CcSEcCtD
Atazanavir—Renal failure—Methotrexate—muscle cancer	0.000242	0.00186	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—muscle cancer	0.000241	0.00185	CcSEcCtD
Atazanavir—Stomatitis—Methotrexate—muscle cancer	0.00024	0.00184	CcSEcCtD
Atazanavir—Hypersensitivity—Vincristine—muscle cancer	0.000239	0.00183	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—muscle cancer	0.000237	0.00182	CcSEcCtD
Atazanavir—Sweating—Methotrexate—muscle cancer	0.000236	0.00181	CcSEcCtD
Atazanavir—Haematuria—Methotrexate—muscle cancer	0.000235	0.0018	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—muscle cancer	0.000235	0.0018	CcSEcCtD
Atazanavir—Dyspnoea—Etoposide—muscle cancer	0.000234	0.0018	CcSEcCtD
Atazanavir—Somnolence—Etoposide—muscle cancer	0.000233	0.00179	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—muscle cancer	0.000233	0.00179	CcSEcCtD
Atazanavir—Asthenia—Vincristine—muscle cancer	0.000232	0.00178	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—muscle cancer	0.00023	0.00177	CcSEcCtD
Atazanavir—Rash—Dactinomycin—muscle cancer	0.000229	0.00175	CcSEcCtD
Atazanavir—Decreased appetite—Etoposide—muscle cancer	0.000228	0.00175	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Etoposide—muscle cancer	0.000227	0.00174	CcSEcCtD
Atazanavir—Fatigue—Etoposide—muscle cancer	0.000226	0.00174	CcSEcCtD
Atazanavir—Constipation—Etoposide—muscle cancer	0.000224	0.00172	CcSEcCtD
Atazanavir—Pain—Etoposide—muscle cancer	0.000224	0.00172	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—muscle cancer	0.000224	0.00172	CcSEcCtD
Atazanavir—Diarrhoea—Vincristine—muscle cancer	0.000222	0.0017	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—muscle cancer	0.000221	0.0017	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—muscle cancer	0.000221	0.0017	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—muscle cancer	0.000218	0.00168	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000218	0.00168	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—muscle cancer	0.000218	0.00167	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—muscle cancer	0.000217	0.00166	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—muscle cancer	0.000216	0.00166	CcSEcCtD
Atazanavir—Feeling abnormal—Etoposide—muscle cancer	0.000216	0.00166	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—muscle cancer	0.000216	0.00166	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—muscle cancer	0.000215	0.00165	CcSEcCtD
Atazanavir—Gastrointestinal pain—Etoposide—muscle cancer	0.000215	0.00165	CcSEcCtD
Atazanavir—Dizziness—Vincristine—muscle cancer	0.000214	0.00164	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000212	0.00162	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—muscle cancer	0.00021	0.00161	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—muscle cancer	0.000209	0.00161	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000209	0.00161	CcSEcCtD
Atazanavir—Urticaria—Etoposide—muscle cancer	0.000208	0.0016	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—muscle cancer	0.000208	0.0016	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—muscle cancer	0.000208	0.0016	CcSEcCtD
Atazanavir—Abdominal pain—Etoposide—muscle cancer	0.000207	0.00159	CcSEcCtD
Atazanavir—Body temperature increased—Etoposide—muscle cancer	0.000207	0.00159	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—muscle cancer	0.000207	0.00159	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—muscle cancer	0.000207	0.00159	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—muscle cancer	0.000206	0.00158	CcSEcCtD
Atazanavir—Vomiting—Vincristine—muscle cancer	0.000206	0.00158	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—muscle cancer	0.000205	0.00158	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—muscle cancer	0.000205	0.00157	CcSEcCtD
Atazanavir—Rash—Vincristine—muscle cancer	0.000204	0.00157	CcSEcCtD
Atazanavir—Dermatitis—Vincristine—muscle cancer	0.000204	0.00157	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—muscle cancer	0.000203	0.00156	CcSEcCtD
Atazanavir—Headache—Vincristine—muscle cancer	0.000203	0.00156	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000202	0.00155	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—muscle cancer	0.000201	0.00154	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—muscle cancer	0.0002	0.00153	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—muscle cancer	0.000199	0.00153	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—muscle cancer	0.000195	0.0015	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—muscle cancer	0.000194	0.00149	CcSEcCtD
Atazanavir—Hypersensitivity—Etoposide—muscle cancer	0.000193	0.00148	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—muscle cancer	0.000193	0.00148	CcSEcCtD
Atazanavir—Nausea—Vincristine—muscle cancer	0.000192	0.00148	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—muscle cancer	0.000192	0.00147	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—muscle cancer	0.000191	0.00146	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—muscle cancer	0.000189	0.00145	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—muscle cancer	0.000189	0.00145	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—muscle cancer	0.000189	0.00145	CcSEcCtD
Atazanavir—Asthenia—Etoposide—muscle cancer	0.000188	0.00144	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—muscle cancer	0.000188	0.00144	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—muscle cancer	0.000188	0.00144	CcSEcCtD
Atazanavir—Back pain—Methotrexate—muscle cancer	0.000186	0.00143	CcSEcCtD
Atazanavir—Pruritus—Etoposide—muscle cancer	0.000186	0.00142	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—muscle cancer	0.000181	0.00139	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—muscle cancer	0.00018	0.00138	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—muscle cancer	0.000179	0.00137	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—muscle cancer	0.000179	0.00137	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—muscle cancer	0.000179	0.00137	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—muscle cancer	0.000178	0.00136	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—muscle cancer	0.000174	0.00133	CcSEcCtD
Atazanavir—Malaise—Methotrexate—muscle cancer	0.000174	0.00133	CcSEcCtD
Atazanavir—Dizziness—Etoposide—muscle cancer	0.000173	0.00133	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—muscle cancer	0.000173	0.00133	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—muscle cancer	0.000173	0.00132	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—muscle cancer	0.000169	0.0013	CcSEcCtD
Atazanavir—Cough—Methotrexate—muscle cancer	0.000168	0.00129	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—muscle cancer	0.000168	0.00129	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—muscle cancer	0.000167	0.00128	CcSEcCtD
Atazanavir—Vomiting—Etoposide—muscle cancer	0.000167	0.00128	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—muscle cancer	0.000167	0.00128	CcSEcCtD
Atazanavir—Rash—Etoposide—muscle cancer	0.000165	0.00127	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—muscle cancer	0.000165	0.00127	CcSEcCtD
Atazanavir—Headache—Etoposide—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Tension—Doxorubicin—muscle cancer	0.000164	0.00126	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—muscle cancer	0.000163	0.00125	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000163	0.00125	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—muscle cancer	0.000162	0.00124	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—muscle cancer	0.000162	0.00124	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—muscle cancer	0.000161	0.00124	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—muscle cancer	0.000158	0.00122	CcSEcCtD
Atazanavir—Infection—Methotrexate—muscle cancer	0.000156	0.0012	CcSEcCtD
Atazanavir—Nausea—Etoposide—muscle cancer	0.000156	0.0012	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—muscle cancer	0.000155	0.00119	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—muscle cancer	0.000154	0.00118	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—muscle cancer	0.000153	0.00118	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—muscle cancer	0.000153	0.00117	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—muscle cancer	0.000152	0.00117	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—muscle cancer	0.00015	0.00115	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—muscle cancer	0.00015	0.00115	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—muscle cancer	0.00015	0.00115	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—muscle cancer	0.000147	0.00113	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—muscle cancer	0.000147	0.00112	CcSEcCtD
Atazanavir—Cough—Doxorubicin—muscle cancer	0.000145	0.00112	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—muscle cancer	0.000144	0.00111	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—muscle cancer	0.000144	0.0011	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000143	0.0011	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—muscle cancer	0.000142	0.00109	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—muscle cancer	0.000142	0.00109	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—muscle cancer	0.000142	0.00109	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—muscle cancer	0.000142	0.00109	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—muscle cancer	0.000141	0.00109	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000141	0.00108	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—muscle cancer	0.00014	0.00108	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—muscle cancer	0.00014	0.00108	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—muscle cancer	0.00014	0.00107	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—muscle cancer	0.000139	0.00107	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—muscle cancer	0.000138	0.00106	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—muscle cancer	0.000137	0.00105	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—muscle cancer	0.000137	0.00105	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—muscle cancer	0.000136	0.00104	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000136	0.00104	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—muscle cancer	0.000135	0.00104	CcSEcCtD
Atazanavir—Infection—Doxorubicin—muscle cancer	0.000135	0.00104	CcSEcCtD
Atazanavir—Pain—Methotrexate—muscle cancer	0.000134	0.00103	CcSEcCtD
Atazanavir—Shock—Doxorubicin—muscle cancer	0.000134	0.00103	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—muscle cancer	0.000133	0.00102	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—muscle cancer	0.000132	0.00101	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—muscle cancer	0.000132	0.00101	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—muscle cancer	0.00013	0.000995	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—muscle cancer	0.00013	0.000994	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—muscle cancer	0.000129	0.000986	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—muscle cancer	0.000125	0.000958	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—muscle cancer	0.000124	0.000953	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—muscle cancer	0.000124	0.000953	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000124	0.000951	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—muscle cancer	0.000123	0.000945	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—muscle cancer	0.000121	0.000931	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—muscle cancer	0.000121	0.000928	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—muscle cancer	0.00012	0.000919	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—muscle cancer	0.000118	0.000908	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000117	0.000902	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—muscle cancer	0.000117	0.0009	CcSEcCtD
Atazanavir—Pain—Doxorubicin—muscle cancer	0.000116	0.000893	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—muscle cancer	0.000116	0.000893	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—muscle cancer	0.000116	0.000889	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—muscle cancer	0.000113	0.000865	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—muscle cancer	0.000112	0.000861	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000111	0.000854	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—muscle cancer	0.000111	0.000853	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—muscle cancer	0.000108	0.00083	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—muscle cancer	0.000108	0.000826	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—muscle cancer	0.000108	0.000826	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—muscle cancer	0.000108	0.000825	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—muscle cancer	0.000104	0.000798	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—muscle cancer	0.0001	0.000769	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—muscle cancer	9.99e-05	0.000767	CcSEcCtD
Atazanavir—Rash—Methotrexate—muscle cancer	9.91e-05	0.00076	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—muscle cancer	9.9e-05	0.00076	CcSEcCtD
Atazanavir—Headache—Methotrexate—muscle cancer	9.85e-05	0.000756	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—muscle cancer	9.76e-05	0.000749	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—muscle cancer	9.63e-05	0.000739	CcSEcCtD
Atazanavir—Nausea—Methotrexate—muscle cancer	9.33e-05	0.000716	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—muscle cancer	9.31e-05	0.000715	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—muscle cancer	9e-05	0.000691	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—muscle cancer	8.65e-05	0.000664	CcSEcCtD
Atazanavir—Rash—Doxorubicin—muscle cancer	8.58e-05	0.000658	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—muscle cancer	8.57e-05	0.000658	CcSEcCtD
Atazanavir—Headache—Doxorubicin—muscle cancer	8.52e-05	0.000654	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—muscle cancer	8.08e-05	0.00062	CcSEcCtD
